Clinical Trials on Urologická onemocnění

Total 16877 results

Velicept Therapeutics, Inc.

Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (VEL-2001)

Overactive Bladder

United States
Astellas Pharma Singapore Pte. Ltd.

Completed

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania

Overactive Bladder (OAB)

Korea, Republic of, Australia
R-Pharm
Synergy Research Inc.

Completed

Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.

Overactive Bladder

Russian Federation
Velicept Therapeutics, Inc.

Completed

Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects

Healthy Subjects, Overactive Bladder
The Hospital of Vestfold
South-Eastern Norway Regional Health Authority

Completed

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

Overactive Bladder

Norway
University Health Network, Toronto
AstraZeneca; University of Toronto; Toronto General Hospital

Completed

Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects (TRANSLATE)

Focal Segmental Glomerulosclerosis

Canada
Mansoura University

Unknown

Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study

Overactive Bladder | Botulinum Toxin | ESWL | Intravesical

Egypt
Northwell Health
Medtronics, Inc.

Completed

UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

Detrusor Overactivity

United States
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Overactive Bladder | Cardiovascular Disease

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.

Overactive Bladder

France
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Kissei Pharmaceutical Co., Ltd.

Withdrawn

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Watson Pharmaceuticals

Completed

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Overactive Bladder

United States
Gulhane School of Medicine

Completed

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

Diabetes | Proteinuria | Renin Angiotensin System

Turkey
Ankara University

Not yet recruiting

Comparison of Single Voiding Cycle and Two and Three Voiding Cycles in Ambulatory Urodynamic Studies

Lower Urinary Tract Symptoms | Urinary Incontinence | Urodynamics | Urogenital Disease, Female

Turkey
Bayer

Completed

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (OVADER)

Overactive Bladder

Austria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
Coloplast A/S

Completed

Performance of a Single-use Intermittent Micro-hole Zone Catheter

Urinary Incontinence | Retention, Urinary

Denmark
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Velicept Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Overactive Bladder

United States
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)

Overactive Bladder
Pfizer

Completed

This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder

Overactive Bladder
Pfizer

Completed

A Bioequivalence Study Of 8 Mg Fesoterodine Extended-Release Tablets (Toviaz™) In Healthy Subjects

Treatment of Overactive Bladder

United States
SHERRY Thomas

Unknown

Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

Urinary Incontinence | Sexual Dysfunction | Vaginal Laxity

United States
BlueWind Medical

Withdrawn

Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1 (OPTIMIST-1)

Overactive Bladder
University of Rochester

Completed

Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?

Overactive Bladder

United States
Buddhist Tzu Chi General Hospital

Completed

Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility

Botulinum Toxins, Type A

Taiwan
Universidad de Valparaiso
Recalcine (GynoPharm)

Completed

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Overactive Bladder

Chile
NYU Langone Health

Terminated

Feasibility of "At-home" Titration of Solifenacin

Overactive Bladder
University of Roma La Sapienza
University Of Perugia

Unknown

Coital Incontinence: Incidence and Quality of Life Impact.

Quality of Life | Urinary Incontinence | Coitus

Italy
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaborators

Completed

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin (OAB)

Overactive Bladder

Korea, Republic of
US Department of Veterans Affairs

Completed

Behavioral Treatment of Overactive Bladder in Men (MOTIVE)

Overactive Bladder

United States
Allergan

Completed

Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Poland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
Ethicon Endo-Surgery
Novella Clinical; Data & Inference, Inc.

Completed

Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)

Overactive Bladder

United States, Sweden, United Kingdom
Zipper Urogynecology Associates

Unknown

Painless Laser Therapy for Overactive Bladder (PLTOAB)

Overactive Bladder

United States
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) (VECTOR)

Overactive Bladder

Canada
APOGEPHA Arzneimittel GmbH

Completed

Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder

Overactive Bladder
University of California, San Francisco
National Institute on Aging (NIA)

Completed

Controlling Urgency Through Relaxation Exercises (CURE)

Overactive Bladder | Urgency Incontinence | Urgency Urinary Symptoms

United States
University of California, San Francisco

Completed

Treatment of Incontinence Without Memory Problems (TRIUMPH)

Urge Incontinence | Urinary Incontinence, Urge

United States
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea

Completed

Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria

Proteinuria

Korea, Republic of
National Taiwan University Hospital

Completed

Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients (OAB)

Urinary Bladder, Overactive
University of Utah
Intermountain Health Care, Inc.

Completed

Preterm Infants and Nephrocalcinosis (NC)

Prematurity | Hypercalciuria | Nephrocalcinosis

United States
University of Aarhus
University Hospital, Ghent

Unknown

Gene Expression in the Overactive Bladder in Children

Overactive Bladder | Children

Denmark
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease

Proteinuria

Mexico
Janssen-Cilag Ltd.,Thailand

Terminated

Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity (RONDO)

Detrusor Function, Overactive

Thailand
Radboud University Medical Center
Astellas Pharma Inc; Continentie Stichting Nederland (Continence Foundation...

Unknown

Study of Overactive Bladder in Women With Prolapse (SOAP)

Urinary Bladder, Overactive | Pelvic Organ Prolapse

Netherlands
Samsung Medical Center

Unknown

The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria

Proteinuria | Chronic Kidney Disease

Korea, Republic of
University of Edinburgh
British Heart Foundation

Completed

Endothelin Receptor Antagonism in Proteinuric Nephropathy

Proteinuria | Chronic Kidney Disease

United Kingdom
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

Proteinuria | Chronic Kidney Disease
Yonsei University

Recruiting

Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome

Prostate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter Cancer | Urological Malignancies

Korea, Republic of

Clinical Trials on Urologická onemocnění

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations